Drug Database
Back to search

Netherlands· NL-01accb8d2281

Ferrofumaraat Teva 200 mg, omhulde tabletten

A ferrous fumarate product containing ferrofumaraat, registered in Netherlands by Teva Nederland B.V.. The same ATC class is registered in 5 of our 19 countries.

ATC B03AA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedFerrofumaraat Teva 200 mg, omhulde ta…ATCB03AA02REGISTER NO.NL-01accb8d2281PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ferrofumaraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ferrous fumarate is registered in 5 of 19 countries.

Countries holding a registration under ATC B03AA02 (ferrous fumarate), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 2 of them publish a price we can compare per daily dose
Search ferrous fumarate products by name

Ferrous fumarate · ATC B03AA02

5 / 19 countries

  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ferrous fumarate costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ferrous fumarate · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.62
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FERROFUMARAAT
Manufacturer
Teva Nederland B.V.
Country
Netherlands (NL)
ATC code
B03AA02
ATC class
Ferrous fumarate
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    50165

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

89 interactions on record for ferrous fumarate.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ferrous fumarate against other medicinesHow interaction checks work

Ferrous fumarate · interactions on record

89 records

  • 3 severe
  • 69 moderate
  • 7 minor

Most severe, free to view

  • DolutegravirJ05AJ03severe
  • DolutegravirJ05AX12severe
  • DimercaprolV03AB09severe
  • Magnesium carbonateA02AA01moderate

10 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under B03AA02

Ferrous fumarate, as other registers publish it.

All ferrous fumarate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ca875950-372a-49fe-9295-0dde19fcde74
GET /v1/drugs/ca875950-372a-49fe-9295-0dde19fcde74?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h50165_smpc.pdf",
  "strength": null,
  "atc_label": "Ferrous Fumarate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg50165",
  "excipients": [
    "HYPROMELLOSE (E 464)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "NATRIUMLAURILSULFAAT",
    "NATRIUMZETMEELGLYCOLAAT",
    "PROPYLEENGLYCOL (E 1520)",
    "TALK (E 553b)"
  ],
  "substances": [
    "FERROFUMARAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h50165.pdf",
  "authorised_at": "1992/03/16",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "50165",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about ferrous fumarate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console